• Global Blood Therapeutics, Inc. (NASDAQ:GBT) rose 19.3% to $40.47 in pre-market trading following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal.
• MGP Ingredients, Inc. (NASDAQ:MGPI) shares jumped 13.3% to $115.50 in pre-market trading after the company posted upbeat Q2 results.
• MercadoLibre, Inc. (NASDAQ:MELI) rose 12.5% to $1,002.66 in pre-market trading following better-than-expected quarterly results.
• Playtika Holding Corp. (NASDAQ:PLTK) rose 11.7% to $14.56 in pre-market trading.
• BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) gained 9.9% to $12.25 in pre-market trading after reporting Q2 results.
• Confluent, Inc. (NASDAQ:CFLT) shares rose 9.6% to $31.80 in pre-market trading following upbeat Q2 results.
• Altice USA, Inc. (NYSE:ATUS) shares surged 9.1% to $10.55 in pre-market trading following strong quarterly sales.
• Sunrun Inc. (NASDAQ:RUN) rose 9% to $33.52 in pre-market trading after the company reported better-than-expected financial results.
• Ecopetrol S.A. (NYSE:EC) gained 5.7% to $11.18 in pre-market trading after the company posted a record net profit for the second quarter.
• Albemarle Corporation (NYSE:ALB) rose 5.7% to $253.17 in pre-market trading after the company posted upbeat Q2 earnings and raised FY22 forecast.
• Novo Nordisk A/S (NYSE:NVO) rose 4.7% to $104.63 in pre-market trading. Novo Nordisk reported Q2 sales of DKK41.27 billion, +25% Y/Y (+15% on a constant currency basis).
• Crocs, Inc. (NASDAQ:CROX) rose 4.3% to $80.70 in pre-market trading.
• Alibaba Group Holding Limited (NYSE:BABA) gained 3.9% to $99.49 in pre-market trading as the company reported first-quarter FY22 flat revenue growth year-on-year to $30.69 billion, beating the consensus of $30.05 billion.

Also check this out: U.S. Stock Futures Edge Higher Ahead of Jobless Claims Data .